Instil Bio Inc (TIL)
26.15
+1.39
(+5.61%)
USD |
NASDAQ |
Nov 22, 16:00
25.91
-0.24
(-0.92%)
After-Hours: 20:00
Instil Bio Cash from Operations (Quarterly): -20.13M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -20.13M |
| June 30, 2024 | -10.61M |
| March 31, 2024 | -14.39M |
| December 31, 2023 | -13.38M |
| September 30, 2023 | -14.43M |
| June 30, 2023 | -19.56M |
| March 31, 2023 | -34.66M |
| December 31, 2022 | -36.98M |
| September 30, 2022 | -40.88M |
| June 30, 2022 | -47.26M |
| Date | Value |
|---|---|
| March 31, 2022 | -55.05M |
| December 31, 2021 | -42.79M |
| September 30, 2021 | -29.40M |
| June 30, 2021 | -32.22M |
| March 31, 2021 | -17.73M |
| December 31, 2020 | -16.82M |
| September 30, 2020 | -7.235M |
| June 30, 2020 | -3.276M |
| March 31, 2020 | -2.282M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-55.05M
Minimum
Mar 2022
-2.282M
Maximum
Mar 2020
-24.16M
Average
-19.56M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Merck & Co Inc | 9.291B |
| Elite Pharmaceuticals Inc | 1.457M |
| BioCardia Inc | -2.611M |
| Zevra Therapeutics Inc | -18.14M |
| NovaBay Pharmaceuticals Inc | -2.061M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 19.81M |
| Cash from Financing (Quarterly) | 0.159M |
| Free Cash Flow | -68.58M |
| Free Cash Flow Per Share (Quarterly) | -4.631 |
| Free Cash Flow Yield | -40.32% |